<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><!-- generator="wordpress/2.2" --><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">

<channel>
	<title>SEBIO News</title>
	<link>http://news.sebio.org</link>
	<description>Just another WordPress weblog</description>
	<pubDate>Mon, 18 May 2009 18:32:48 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2</generator>
	<language>en</language>
			<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/SebioNews" type="application/rss+xml" /><feedburner:emailServiceId xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">SebioNews</feedburner:emailServiceId><feedburner:feedburnerHostname xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">http://feedburner.google.com</feedburner:feedburnerHostname><item>
		<title>Southeast BIO Names New Executive Director</title>
		<link>http://news.sebio.org/2009/05/18/southeast-bio-names-new-executive-director/</link>
		<comments>http://news.sebio.org/2009/05/18/southeast-bio-names-new-executive-director/#comments</comments>
		<pubDate>Mon, 18 May 2009 14:36:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[SEBIO News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/05/18/southeast-bio-names-new-executive-director/</guid>
		<description><![CDATA[Atlanta, GA- Southeast BIO (SEBIO), a public/private partnership formed in 1999 to promote the growth of the life sciences economy in the Southeast, has named Jennifer Moore, Ph.D., as its new Executive Director. Dr. Moore replaces Stephanie Adams, SEBIO’s second Executive Director.
]]></description>
			<content:encoded><![CDATA[<p>Atlanta, GA- Southeast BIO (SEBIO), a public/private partnership formed in 1999 to promote the growth of the life sciences economy in the Southeast, has named Jennifer Moore, Ph.D., as its new Executive Director. Dr. Moore replaces Stephanie Adams, SEBIO’s second Executive Director.  <a href="http://news.sebio.org/2009/05/18/southeast-bio-names-new-executive-director/#more-237" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/05/18/southeast-bio-names-new-executive-director/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Ten Semifinalists Selected in SEBIO’s Third Annual BIO/Plan Competition</title>
		<link>http://news.sebio.org/2009/05/13/en-semifinalists-selected-in-sebios-third-annual-bioplan-competition/</link>
		<comments>http://news.sebio.org/2009/05/13/en-semifinalists-selected-in-sebios-third-annual-bioplan-competition/#comments</comments>
		<pubDate>Wed, 13 May 2009 17:20:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[SEBIO News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/05/13/en-semifinalists-selected-in-sebios-third-annual-bioplan-competition/</guid>
		<description><![CDATA[Atlanta, GA - Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast&#8217;s life sciences industry, announced today that it has selected ten semifinalists in its third annual BIO/Plan Competition.
]]></description>
			<content:encoded><![CDATA[<p>Atlanta, GA - Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast&#8217;s life sciences industry, announced today that it has selected ten semifinalists in its third annual BIO/Plan Competition.  <a href="http://news.sebio.org/2009/05/13/en-semifinalists-selected-in-sebios-third-annual-bioplan-competition/#more-236" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/05/13/en-semifinalists-selected-in-sebios-third-annual-bioplan-competition/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Applied Genetic Technologies raises $11.8M round</title>
		<link>http://news.sebio.org/2009/05/01/applied-genetic-technologies-raises-118m-round/</link>
		<comments>http://news.sebio.org/2009/05/01/applied-genetic-technologies-raises-118m-round/#comments</comments>
		<pubDate>Fri, 01 May 2009 20:16:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Regional Venture News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/05/01/applied-genetic-technologies-raises-118m-round/</guid>
		<description><![CDATA[GAINSVILLE, FL - Applied Genetic Technologies Corp., a clinical stage biotechnology company has closed on an $11,800,000 financing round led by InterWest Partners of Menlo Park, CA. Other participants in the round include Intersouth Partners and MedImmune Ventures Inc.
]]></description>
			<content:encoded><![CDATA[<p>GAINSVILLE, FL - Applied Genetic Technologies Corp., a clinical stage biotechnology company has closed on an $11,800,000 financing round led by InterWest Partners of Menlo Park, CA. Other participants in the round include Intersouth Partners and MedImmune Ventures Inc.  <a href="http://news.sebio.org/2009/05/01/applied-genetic-technologies-raises-118m-round/#more-235" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/05/01/applied-genetic-technologies-raises-118m-round/feed/</wfw:commentRss>
		</item>
		<item>
		<title>BIO International Convention: BIO and Atlanta Set to Help Heal, Fuel, Feed the World</title>
		<link>http://news.sebio.org/2009/05/01/bio-international-convention-bio-and-atlanta-set-to-help-heal-fuel-feed-the-world/</link>
		<comments>http://news.sebio.org/2009/05/01/bio-international-convention-bio-and-atlanta-set-to-help-heal-fuel-feed-the-world/#comments</comments>
		<pubDate>Fri, 01 May 2009 20:13:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Other Regional News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/05/01/bio-international-convention-bio-and-atlanta-set-to-help-heal-fuel-feed-the-world/</guid>
		<description><![CDATA[This month, BIO and its partners within the Southeast will host the 2009 BIO International Convention, the largest gathering of the global biotech industry. The convention attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
]]></description>
			<content:encoded><![CDATA[<p>This month, BIO and its partners within the Southeast will host the 2009 BIO International Convention, the largest gathering of the global biotech industry. The convention attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.  <a href="http://news.sebio.org/2009/05/01/bio-international-convention-bio-and-atlanta-set-to-help-heal-fuel-feed-the-world/#more-234" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/05/01/bio-international-convention-bio-and-atlanta-set-to-help-heal-fuel-feed-the-world/feed/</wfw:commentRss>
		</item>
		<item>
		<title>GlaxoSmithKline acquiring Stiefel Laboratories for $2.9B</title>
		<link>http://news.sebio.org/2009/04/20/glaxosmithkline-acquiring-stiefel-laboratories-for-29b/</link>
		<comments>http://news.sebio.org/2009/04/20/glaxosmithkline-acquiring-stiefel-laboratories-for-29b/#comments</comments>
		<pubDate>Mon, 20 Apr 2009 16:52:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Other Regional News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/04/20/glaxosmithkline-acquiring-stiefel-laboratories-for-29b/</guid>
		<description><![CDATA[RESEARCH TRIANGLE PARK, NC - UK-based GlaxoSmithKline, which has U.S. headquarters in the RTP, has purchased Stiefel Laboratories of Coral Gables, FL, for $2.9 billion.
]]></description>
			<content:encoded><![CDATA[<p>RESEARCH TRIANGLE PARK, NC - UK-based GlaxoSmithKline, which has U.S. headquarters in the RTP, has purchased Stiefel Laboratories of Coral Gables, FL, for $2.9 billion.  <a href="http://news.sebio.org/2009/04/20/glaxosmithkline-acquiring-stiefel-laboratories-for-29b/#more-231" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/04/20/glaxosmithkline-acquiring-stiefel-laboratories-for-29b/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Altea Therapeutics Announces Development and Commercialization Agreement with Amylin and Lilly for an Investigational Transdermal Exenatide</title>
		<link>http://news.sebio.org/2009/04/20/altea-therapeutics-announces-development-and-commercialization-agreement-with-amylin-and-lilly-for-an-investigational-transdermal-exenatide/</link>
		<comments>http://news.sebio.org/2009/04/20/altea-therapeutics-announces-development-and-commercialization-agreement-with-amylin-and-lilly-for-an-investigational-transdermal-exenatide/#comments</comments>
		<pubDate>Mon, 20 Apr 2009 16:48:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Other Regional News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/04/20/altea-therapeutics-announces-development-and-commercialization-agreement-with-amylin-and-lilly-for-an-investigational-transdermal-exenatide/</guid>
		<description><![CDATA[ATLANTA, Ga.- Altea Therapeutics announced today that it has entered into an agreement with Eli Lilly and Company and Amylin Pharmaceuticals, Inc. to develop and commercialize a novel daily transdermal patch delivering sustained levels of exenatide utilizing the Altea Therapeutics proprietary PassPort® Transdermal Delivery System.
]]></description>
			<content:encoded><![CDATA[<p>ATLANTA, Ga.- Altea Therapeutics announced today that it has entered into an agreement with Eli Lilly and Company and Amylin Pharmaceuticals, Inc. to develop and commercialize a novel daily transdermal patch delivering sustained levels of exenatide utilizing the Altea Therapeutics proprietary PassPort® Transdermal Delivery System.  <a href="http://news.sebio.org/2009/04/20/altea-therapeutics-announces-development-and-commercialization-agreement-with-amylin-and-lilly-for-an-investigational-transdermal-exenatide/#more-229" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/04/20/altea-therapeutics-announces-development-and-commercialization-agreement-with-amylin-and-lilly-for-an-investigational-transdermal-exenatide/feed/</wfw:commentRss>
		</item>
		<item>
		<title>GSK/Pfizer HIV Collaboration to Make Home in RTP</title>
		<link>http://news.sebio.org/2009/04/17/gskpfizer-hiv-collaboration-to-make-home-in-rtp/</link>
		<comments>http://news.sebio.org/2009/04/17/gskpfizer-hiv-collaboration-to-make-home-in-rtp/#comments</comments>
		<pubDate>Fri, 17 Apr 2009 17:07:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Other Regional News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/04/17/gskpfizer-hiv-collaboration-to-make-home-in-rtp/</guid>
		<description><![CDATA[Research Triangle Park, NC&#8211; Pharma giants GlaxoSmithKline and Pfizer will be combining their HIV portfolio to create a new company. The Raleigh News &#038; Observer reported that the U.S. headquarters of the new venture will be in Research Triangle Park.
]]></description>
			<content:encoded><![CDATA[<p>Research Triangle Park, NC&#8211; Pharma giants GlaxoSmithKline and Pfizer will be combining their HIV portfolio to create a new company. The Raleigh News &#038; Observer reported that the U.S. headquarters of the new venture will be in Research Triangle Park. <a href="http://news.sebio.org/2009/04/17/gskpfizer-hiv-collaboration-to-make-home-in-rtp/#more-233" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/04/17/gskpfizer-hiv-collaboration-to-make-home-in-rtp/feed/</wfw:commentRss>
		</item>
		<item>
		<title>University of Florida Event Matches Researchers, Investors</title>
		<link>http://news.sebio.org/2009/04/15/university-of-florida-event-matches-researchers-investors/</link>
		<comments>http://news.sebio.org/2009/04/15/university-of-florida-event-matches-researchers-investors/#comments</comments>
		<pubDate>Wed, 15 Apr 2009 16:54:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Other Regional News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/04/15/university-of-florida-event-matches-researchers-investors/</guid>
		<description><![CDATA[The University of Florida&#8217;s Technology Licensing office held its version of speed dating Tuesday. But instead of matching prospective mates, the Celebration of Innovation Showcase touted the virtues of university research inventions and spin-off companies to prospective entrepreneurs and investors.
Despite the down economy, the event grew in its third year, with 339 registrants, up by [...]]]></description>
			<content:encoded><![CDATA[<p>The University of Florida&#8217;s Technology Licensing office held its version of speed dating Tuesday. But instead of matching prospective mates, the Celebration of Innovation Showcase touted the virtues of university research inventions and spin-off companies to prospective entrepreneurs and investors.</p>
<p>Despite the down economy, the event grew in its third year, with 339 registrants, up by about 100 people. That included more investors, with representatives from 20 venture capital firms, inventors, entrepreneurs and service providers such as attorneys, according to tech licensing director David Day. <a href="http://news.sebio.org/2009/04/15/university-of-florida-event-matches-researchers-investors/#more-232" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/04/15/university-of-florida-event-matches-researchers-investors/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Piedmont Pharmaceuticals Lands $5 Million Investment</title>
		<link>http://news.sebio.org/2009/04/07/piedmont-pharmaceuticals-lands-5-million-investment/</link>
		<comments>http://news.sebio.org/2009/04/07/piedmont-pharmaceuticals-lands-5-million-investment/#comments</comments>
		<pubDate>Tue, 07 Apr 2009 16:48:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Regional Venture News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/04/07/piedmont-pharmaceuticals-lands-5-million-investment/</guid>
		<description><![CDATA[Greensboro, N.C.– Piedmont Pharmaceuticals LLC, a specialty pharmaceuticals company focused on parasitology and drug delivery systems for companion animal and human use, has successfully raised $5 million in equity financing led by CM Capital Investments of Brisbane, Australia.
]]></description>
			<content:encoded><![CDATA[<p>Greensboro, N.C.– Piedmont Pharmaceuticals LLC, a specialty pharmaceuticals company focused on parasitology and drug delivery systems for companion animal and human use, has successfully raised $5 million in equity financing led by CM Capital Investments of Brisbane, Australia. <a href="http://news.sebio.org/2009/04/07/piedmont-pharmaceuticals-lands-5-million-investment/#more-230" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/04/07/piedmont-pharmaceuticals-lands-5-million-investment/feed/</wfw:commentRss>
		</item>
		<item>
		<title>SEBIO ANNOUNCES ELEVENTH ANNUAL INVESTOR FORUM</title>
		<link>http://news.sebio.org/2009/03/26/sebio-announces-eleventh-annual-investor-forum/</link>
		<comments>http://news.sebio.org/2009/03/26/sebio-announces-eleventh-annual-investor-forum/#comments</comments>
		<pubDate>Thu, 26 Mar 2009 16:11:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[SEBIO News]]></category>

		<guid isPermaLink="false">http://news.sebio.org/2009/03/26/sebio-announces-eleventh-annual-investor-forum/</guid>
		<description><![CDATA[REGION’S PREMIER LIFE SCIENCES VENTURE CONFERENCE ATTRACTS EMERGING COMPANIES AND INVESTORS
Atlanta, GA March 26, 2009 - Southeast BIO (SEBIO) today announced its 2009 SEBIO Investor Forum, set for December 3-4, 2009, at the Charleston Place Hotel in Charleston, SC.
]]></description>
			<content:encoded><![CDATA[<p>REGION’S PREMIER LIFE SCIENCES VENTURE CONFERENCE ATTRACTS EMERGING COMPANIES AND INVESTORS</p>
<p>Atlanta, GA March 26, 2009 - Southeast BIO (SEBIO) today announced its 2009 SEBIO Investor Forum, set for December 3-4, 2009, at the Charleston Place Hotel in Charleston, SC.  <a href="http://news.sebio.org/2009/03/26/sebio-announces-eleventh-annual-investor-forum/#more-225" class="more-link">(more&#8230;)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://news.sebio.org/2009/03/26/sebio-announces-eleventh-annual-investor-forum/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
